✦ LIBER ✦

Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients

✍ Scribed by R. Jakesz; H. Samonigg; M. Gnant; E. Kubista; P. Steindorfer; H. Hausmaninger; P. Sevelda; B. Tschurtschenthaler; M. Fridrik; M. Stierer; R. Kolb; G. Steger; the Austrian Breast Cancer Study Group

Book ID: 117664097
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 89 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)10010-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

97 P - Low dose, short-term adjuvant che

97 P - Low dose, short-term adjuvant chemotherapy in stage I hormone receptor negative breast cancer

✍ R. Jakesz; H. Hausmaninger; H. Samonigg; E. Kubista; M. Gnant; G. Steger 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Predictors of reduced dose intensity in

Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy

✍ Michelle Shayne; Jeffrey Crawford; David C. Dale; Eva Culakova; Gary H. Lyman; f 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 295 KB

The optimal dose of CAF regimen in adjuv

The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB

✍ Hamid Khaloozadeh; Pedram Yazdanbakhsh; Fatemeh Homaei-shandiz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 664 KB

Predictors of timing of adjuvant chemoth

Predictors of timing of adjuvant chemotherapy in older women with hormone receptor–negative, stages II–III breast cancer

✍ Stephanie B. Wheeler; William R. Carpenter; Jeffrey Peppercorn; Anna P. Schenck; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 215 KB

Combined treatment with biphosphonates,

Combined treatment with biphosphonates, low-dose chemotherapy, and trastuzumab in receptor-negative breast cancer patients with bone marrow involvement

✍ S Bezares; M.L Amador; D Castellano; J.M Trigo; H Cortés-Funes; R Colomer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Patients’ preferences for adjuvant chemo

Patients’ preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

✍ Jansen, S J T; Kievit, J; Nooij, M A; Haes, J C J M de; Overpelt, I M E; Slooten 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB